Loading...
Corum Group announces $3.3 million investment from Arrotex.
Generic and private label OTC company Arrotex will take 60 million shares in listed pharmacy software specialist Corum Group, as part of a capital raising which will inject $3.3 million into the business.
Arrotex Executive Chairman, Dennis Bastas, will join the Corum Board, with the funding to be used to "accelerate key product development and business expansion".
More in today's issue of Pharmacy Daily.
This Pharmacy Daily breaking news is brought to you by JPH Group
To ensure you continue to receive email from Pharmacy Daily reliably please add info@pharmacydaily.com.au to your 'Safe Senders' list and set images to always display.
To forward this email to a friend click here. To receive your own copy of Pharmacy Daily sign up here.
To modify subscription details click here. To unsubscribe click here.
The Therapeutic Goods Advertising Code 2015 requires strict compliance. View the code here.
Pharmacy Daily - a division of Business Publishing Group
PO Box 1010 Epping NSW Australia 1710
Level 2, Suite 1 64 Talavera Rd Macquarie Park NSW 2113
Loading...
Loading...
